ALXO CIK: 1810182

ALX Oncology Holdings Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
–
FY24:
–
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−83.6
FY22:
−127
FY23:
−170
FY24:
−142
FY25:
−104
(positive)
Change from FY21 to FY24
millions USD
FY21:
−83.4
FY22:
−123
FY23:
−158
FY24:
−132
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−83.5
FY22:
−123
FY23:
−161
FY24:
−135
FY25:
−102
(positive)
Change from FY21 to FY25
millions USD
FY21:
−83.5
FY22:
−123
FY23:
−161
FY24:
−135
FY25:
−102

All amounts in millions USD Data sources:SEC EDGARTwelve Data